![Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide | BMC Cancer | Full Text Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-023-10700-0/MediaObjects/12885_2023_10700_Fig1_HTML.png)
Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide | BMC Cancer | Full Text
![JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy](https://pub.mdpi-res.com/jpm/jpm-09-00019/article_deploy/html/images/jpm-09-00019-g002.png?1571415812)
JPM | Free Full-Text | A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy
![Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer | Cell Death & Disease Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-021-03909-z/MediaObjects/41419_2021_3909_Fig1_HTML.png)
Diagnostic and prognostic potential of the proteomic profiling of serum-derived extracellular vesicles in prostate cancer | Cell Death & Disease
![Frontiers | Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study Frontiers | Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study](https://www.frontiersin.org/files/Articles/770169/fsurg-08-770169-HTML/image_m/fsurg-08-770169-g001.jpg)
Frontiers | Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study
![Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol | BMJ Open Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/11/2/e040531/F1.large.jpg)
Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol | BMJ Open
![Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/3a795313-8b7c-4853-8e86-8144a06e887b/gr3.jpg)
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort - European Urology Focus Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/8ab1a23f-71c9-42e5-9542-5365a452035a/gr1.jpg)
Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort - European Urology Focus
![Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer](https://www.mdpi.com/cells/cells-09-02116/article_deploy/html/images/cells-09-02116-g001-550.jpg)
Cells | Free Full-Text | Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer
![Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care](https://cambridgeprostatecancer.com/wp-content/uploads/CPG-mortality-charts.jpg)